medRxiv : the preprint server for health sciences · 10 Jun 2026
Multi-ancestry genome-wide association study and meta-analysis of stimulant use disorder reveals biology and relationships to other psychiatric disorders
Sarah E. Beck, Joseph D. Deak, Daniel F. Levey, Tian Ge, Paul W. Jeffries, Dongbing Lai, Travis T. Mallard, Louisa Degenhardt, Penelope A. Lind, Trine Tollerup Nielsen, Justin D. Tubbs, Leah Wetherill, Emma C. Johnsonh-index 28, Alexander S. Hatoum, The SUD Working Group of the Psychiatric Genomics Consortium, COGA Collaborators, Yale-Penn Collaboration, The VA Million Veteran Program, Anders D. Børglum, Ditte Demontis, Sarah E. Medland, Nicholas G. Martin, Elliot C. Nelson, Jordan W. Smoller, Henry R. Kranzlerh-index 32, J. Michael Gaziano, Murray B. Stein, Arpana Agrawal, Howard J. Edenberg, Joel Gelernterh-index 99
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Abstract Stimulant use disorder (StimUD) is a significant public health problem, but genetic studies have been limited by small sample sizes. We conducted genome-wide association studies (GWAS) of StimUD in the Million Veteran Program (MVP) and All of Us (AOU), followed by meta-analysis with FinnGen and 10 additional datasets, for a total of 709,369 individuals (N cases =33,977, N controls =675,392) in four broad ancestry groups: European (EUR) (N cases =22,564, N controls =624,672), African (AFR) (N cases =7,574, N controls =34,189), Admixed American (AMR) (N cases =3,657, N controls =15,698), and East Asian (EAS) (N cases =182, N controls =833). Population-specific SNP heritability was 6.1% in EUR and 2.4% in AFR. We discovered a total of 19 genome-wide-significant loci, six in EUR, including DRD2 *rs5794864, P =7.32×10 −10 , one in AFR, five in a multi-ancestry meta-analysis, including CHRNA5 *rs55781567, P =3.27×10 −9 , two in a male-only meta-analysis, including FTO *rs8057044, P =9.50×10 −9 , and five in a meta-analysis of sex-stratified results. In a hold-out AOU subsample (N EUR =18,841, N AFR =12,263, N AMR =9,739), ancestry-specific polygenic risk scores were significantly associated with StimUD in EUR (OR=3.28, 95% confidence interval (CI)=2.89-3.71) and AMR (OR=2.01, 95% CI=1.71-2.37). Transcriptome-wide association studies, fine-mapping, and colocalization analyses prioritized additional genes (e.g., GPX1 , BSN ). Genetic correlation, Mendelian randomization, and causal mixture analyses revealed relationships with other substance use and use disorder phenotypes, including cannabis use disorder (r g =0.94, P =5.43×10 −237 ) and opioid use disorder (r g =1.01, P =4.40×10 −107 ), and other psychiatric traits, including anxiety, depression, neuroticism, and attention-deficit/hyperactivity disorder. This is the first well-powered GWAS of StimUD, and it offers significant insights into disease biology.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Joel Gelernter has the highest h-index among the authors (99).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (98)
What it cites, from open citation data, with Crossref's record of each.
Sign in to see 78 more references
A free account opens the rest of the citing papers and references on every paper’s page.